Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,528.00 -3.00 (-0.20%)

Bid:

1,526.00

Ask:

1,529.00

Spread: 3.00 (0.197%)

Market Cap: £3.22b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Hikma Pharmaceuticals News

LONDON MARKET PRE-OPEN: Lower Call As AstraZeneca Earnings Slip

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday after the FTSE 100 set a record closing high on Thursday, ...

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 14 May CerillionHalf Year ResultsDignityQ1 Year Year Year 15 GroupFull 16

UK Shareholder Meetings Calendar - Next 7 Days

Monday 14 MayCentricaMidwich GroupSafecharge International GroupTuesday 15 16

Hikma Pharmaceuticals Subsidiary West-Ward Launches Cancer Drug In US

LONDON (Alliance News) - On Thursday Hikma Pharmaceuticals PLC said its wholly-owned US subsidiary West-Ward Pharmaceuticals Corp has launched a new c...

WINNERS & LOSERS SUMMARY: Reckitt Slides After Missing Forecasts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - LOSERS-...

Hikma Subsidiary West-Ward Launches Dexrazoxane For Injection

LONDON (Alliance News) - Hikma Pharmaceuticals PLC on Friday said a US subsidiary has launched its version of Dexrazoxane for Injection, a generic equ...

Hikma Subsidiary Launches Palonosetron Hydrochloride Injection

LONDON (Alliance News) - Hikma Pharmaceuticals PLC said on Thursday its wholly owned US subsidiary West-Ward Pharmaceuticals Corp has launched Palonos...

Wall St Week Ahead-Globalists buck U.S. index fund trend

By Trevor Hunnicutt NEW YORK, March 23 (Reuters) - Volatility in U.S. equity markets this year is pushing investors not only to invest in stocks abro...